Psychiatry and Neurology, Neurology · New York, NY
NPI
1528155611
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
401 E 55th St
New York, NY, 10022
Phone (212) 593-6262
Medicare paid, 2024
$522K
11,659 services
Medicare patients, 2024
157
Average age 69
Drug cost, 2024
$4.3M
1,775 prescriptions
Company payments, 2025
$10K
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Brian R Apatoff was code J2350 (injection, ocrelizumab, 1 mg), 10,200 times for 17 patients. In total Brian R Apatoff billed 11,659 services in 12 codes, and Medicare paid $522K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-05-04.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J2350 Injection, ocrelizumab, 1 mg | Office | 10,200 | 17 | $46.83 | $478K |
| 99213 Office E&M - Established | Office | 203 | 121 | $77.72 | $16K |
| 99212 Office E&M - Established | Office | 124 | 51 | $44.52 | $5,520 |
| J2930 Injection, methylprednisolone sodium succinate, up to 125 mg | Office | 88 | 11 | $4.61 | $406 |
| J7042 5% dextrose/normal saline (500 ml = 1 unit) | Office | 39 | 25 | $1.01 | $39.35 |
| 96413 Chemotherapy Administration | Office | 36 | 22 | $117.85 | $4,243 |
| 96415 Chemotherapy Administration | Office | 27 | 21 | $24.93 | $673 |
| 36415 Venipuncture Blood Collection | Office | 14 | 14 | $8.65 | $121 |
| 99203 Office E&M - New | Office | 13 | 13 | $99.64 | $1,295 |
| 99204 Office E&M - New | Office | 12 | 12 | $148.57 | $1,783 |
By year: 2022 $623K for 14,244 services; 2023 $720K for 16,049 services; 2024 $522K for 11,659 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 14 | 14 | $8.65 | $121 |
Medicare prescription drug claims, 2024
In 2024, the drug Brian R Apatoff prescribed most often to Medicare patients was Gabapentin, with 354 prescriptions and refills. In total Brian R Apatoff wrote 1,775 Medicare prescriptions that cost $4.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gabapentin Generic | 354 | 553 | 84 | $8,685 |
| Avonex (4 Pack) Interferon Beta-1a | 157 | 179 | 15 | $1.5M |
| Copaxone Glatiramer Acetate | 86 | 101 | Under 11 | $616K |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 68 | 68 | 15 | $1,441 |
| Prednisone Generic | 66 | 66 | 30 | $291 |
| Zolpidem Tartrate Generic | 51 | 51 | Under 11 | $249 |
| Glatopa Glatiramer Acetate | 48 | 48 | Under 11 | $72K |
| Baclofen Generic | 48 | 99 | 16 | $1,171 |
| Avonex Pen (4 Pack) Interferon Beta-1a | 44 | 44 | Under 11 | $374K |
| Duloxetine Hcl Generic | 37 | 75 | Under 11 | $886 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 32 | 38 | Under 11 | $1,162 |
| Fentanyl Generic | 30 | 30 | Under 11 | $3,105 |
| Dextroamphetamine-Amphetamine Dextroamphetamine/Amphetamine | 29 | 31 | Under 11 | $1,177 |
| Morphine Sulfate Er Morphine Sulfate | 28 | 28 | Under 11 | $1,131 |
| Glatiramer Acetate Generic | 26 | 26 | Under 11 | $49K |
Brand drugs: - claims; generic drugs: 1,339 claims; opioid claims: 244.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Brian R Apatoff $10K ($10K in general payments such as food, travel and fees) from 15 companies. The largest payer was Amgen Inc. with $3,259.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 26 | $3,259 |
| TG Therapeutics, Inc. TGTX | 16 | $2,285 |
| Biogen, Inc. BIIB | 14 | $1,979 |
| Novartis Pharmaceuticals Corporation NVS | 33 | $604 |
| EMD Serono, Inc. MRK.DE | 12 | $498 |
| Alexion Pharmaceuticals, Inc. AZN | 12 | $321 |
| Celgene Corporation BMY | 10 | $252 |
| Vanda Pharmaceuticals Inc. VNDA | 5 | $187 |
| Abbvie Inc. ABBV | 9 | $176 |
| Pfizer Inc. PFE | 9 | $164 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.